NCT00895635

Brief Summary

Peripheral arterial disease (PAD) is a disorder that affects more than 8 million people in the United States. As a result of decreased blood flow to the legs, people with PAD may experience leg pain and difficulty with walking. This study will examine the effectiveness of two exercise programs-a treadmill walking program and an aerobic arm exercise program-at increasing walking distance and decreasing leg pain in people with PAD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jan 2009

Longer than P75 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 6, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 8, 2009

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2014

Completed
Last Updated

November 1, 2019

Status Verified

October 1, 2019

Enrollment Period

5.2 years

First QC Date

May 6, 2009

Last Update Submit

October 30, 2019

Conditions

Keywords

ClaudicationPeripheral Arterial DiseaseExercise RehabilitationCardiovascular Function

Outcome Measures

Primary Outcomes (2)

  • Maximal walking distance

    Measured at baseline and Weeks 6, 12, and 24

  • Pain-free walking distance

    Measured at baseline and Weeks 6, 12, and 24

Secondary Outcomes (3)

  • Limb blood flow

    Measured at baseline and Weeks 6, 12, and 24

  • Cardiovascular function

    Measured at baseline and Weeks 6, 12, and 24

  • Quality of life

    Measured at baseline and Weeks 6, 12, and 24

Study Arms (3)

Treadmill Exercise Training

EXPERIMENTAL

Participants will take part in a 12-week supervised treadmill exercise training program.

Behavioral: Treadmill Exercise Training

Arm Ergometry Exercise Training

EXPERIMENTAL

Participants will take part in a 12-week supervised aerobic arm ergometry exercise training program.

Behavioral: Arm Ergometry Exercise Training

Usual Care Control Group

ACTIVE COMPARATOR

Participants will receive usual care for PAD from their doctor.

Behavioral: Usual Care

Interventions

60-minute sessions of supervised treadmill exercise training three times a week for 12 weeks

Treadmill Exercise Training

60-minute sessions of supervised aerobic arm exercise training using an arm ergometer three times a week for 12 weeks

Arm Ergometry Exercise Training
Usual CareBEHAVIORAL

Usual care for PAD

Usual Care Control Group

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Has lifestyle-limiting claudication
  • Able to walk on a treadmill at 2 mph
  • Able to perform arm ergometry exercise
  • Able to complete a 12-week exercise program

You may not qualify if:

  • Physical activities are limited for reasons other than claudication
  • Uncontrolled high blood pressure
  • Uncontrolled diabetes
  • Unstable coronary heart disease
  • Ischemic rest pain or tissue loss
  • Recent (in the 3 months before study entry) coronary or peripheral revascularization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota

Minneapolis, Minnesota, 55455, United States

Location

MeSH Terms

Conditions

Intermittent ClaudicationPeripheral Vascular DiseasesPeripheral Arterial Disease

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsAtherosclerosisArteriosclerosisArterial Occlusive Diseases

Study Officials

  • Diane J. Treat-Jacobson, PhD, RN

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2009

First Posted

May 8, 2009

Study Start

January 1, 2009

Primary Completion

April 1, 2014

Study Completion

April 1, 2014

Last Updated

November 1, 2019

Record last verified: 2019-10

Locations